BCBS is consulting on amendments to the treatment of client cleared derivatives under the Basel III leverage ratio. This consultative document seeks views on whether a targeted and limited revision of the leverage ratio's treatment of client cleared derivatives may be warranted. Comments are requested by January 16, 2019.
BCBS is consulting on whether a targeted and limited revision of the treatment of leverage ratio of client cleared derivatives may be warranted. This proposal is based on the findings of the BCBS review of the impact of the leverage ratio on banks' provision of client clearing services. The proposal also considers the key policy objectives of G20 leaders to prevent excessive leverage and improve the quality and quantity of capital in the banking system and to promote central clearing of standardized derivatives contracts. Stakeholders are invited to provide concrete and robust empirical evidence to support their views. The range of treatments that BCBS may consider include:
- No change to the current treatment
- An amendment to the treatment of client cleared derivatives to allow cash and non-cash initial margin received from a client to offset the potential future exposure of client cleared derivatives
- Alignment of the treatment of client cleared derivatives with the standardized approach for measuring counterparty credit risk exposures (SA-CCR).
The alignment of the treatment of client cleared derivatives with SA-CCR would have the effect of allowing both cash and non-cash forms of initial margin and variation margin received from a client to offset the replacement cost and the potential future exposure amounts of client cleared derivatives. In addition, BCBS is requesting feedback on the merits of introducing a requirement for initial margin to be segregated in order for any amended leverage ratio treatment to apply. Views are also being sought on the forward-looking behavioral dynamics of the client clearing industry that might result from any amended treatment.
Comment Due Date: January 16, 2019
Keywords: International, Banking, Client Cleared Derivatives, SA-CCR, CCP, Basel III, Leverage Ratio, BCBS
APRA has concluded its review of the comprehensive plans of authorized deposit-taking institutions for the assessment and management of loans with repayment deferrals.
ESAs (EBA, EIOPA, and ESMA) published the first joint report that assesses risks in the financial sector since the outbreak of the COVID-19 pandemic.
BoE and HM Treasury confirmed that the COVID Corporate Financing Facility (CCFF) will close for new purchases of commercial paper, with effect from March 23, 2021.
ECB published a decision allowing the euro area banks under its direct supervision to exclude certain central bank exposures from the leverage ratio.
ESAs launched a survey seeking feedback on the presentational aspects of product templates under the Sustainable Finance Disclosure Regulation (SFDR or Regulation 2019/2088).
ECB published input of the European System of Central Banks (ESCB) into the EBA feasibility report on reducing the reporting burden for banks in EU.
EC adopted a decision determining, for a limited period of time, that the regulatory framework applicable to central counterparties, or CCPs, in the UK and Northern Ireland is equivalent to the requirements laid down in the European Market Infrastructure Regulation (EMIR or Regulation 648/2012).
EBA has decided to phase out the guidelines on legislative and non-legislative moratoria of loan repayments, in accordance with the earlier specified end of September deadline.
EBA published an Opinion addressed to EC to raise awareness about the opportunity to clarify certain issues related to the definition of credit institution in the upcoming review of the Capital Requirements Directive and Regulation (CRD and CRR).
ECB finalized the guide on assessment methodology for the internal model method for calculating exposure to counterparty credit risk (CCR) and the advanced method for own funds requirements for credit valuation adjustment (A-CVA) risk.